We are delighted to invite you to the Rb-NET Challenges 2024 - an online webinar aimed for clinicians engaged in retinoblastoma management.

A 1-hour online webinar for clinicians engaged in retinoblastoma management, in which colleagues from across the world will present short case reports (rapid fire) of challenging RB cases.

In addition, we will have a "real" live MDT meeting (tumor board), including pediatric oncologists, ophthalmologists, pathologists and radiologists. Hoping to see you online.

iVista Medical Education, Inc., along with our Course Director, Prithvi Mruthyunjaya, is excited to invite you to sponsor the 2nd annual INNOVATE Ocular Oncology, scheduled for Saturday, November 2, 2024, at the Stanford Center for Academic Medicine in Palo Alto, California, from 7:00 AM to 5:00 PM PT.

INNOVATE Ocular Oncology continues in the tradition of our INNOVATE series, where scientific, clinical, and industry leaders come together to educate and inform participants on the state-of-the-art and future trends in ocular oncology. This is a critical time in this field- even with the approval of new therapies, increased clinical trial options, and advanced diagnostics, there are still unmet needs regarding treatment burden, toxicities, and access to care. INNOVATE Ocular Oncology aims to address these issues head-on with provocative lectures, cutting-edge research presentations, and panel discussions with leaders in biopharma. The hallmark of this meeting rests with hard questions, lively discussion, and a collegial inter-disciplinary environment.

Register for Event

Visit Website

Ohio Ocular Oncology (Virtual) Symposium
Genetics of Ocular Melanoma

A Zoom link will be sent to registrants closer to the symposium date. 

Register Here

During this webinar, Dr. Berry will discuss the diagnosis, routine clinical management, and recent imaging and research innovations for a rare pediatric intraocular tumor, retinoblastoma (RB). After this lecture, you will be able to (1) identify the must-not-miss clinical features for diagnosis of RB, (2) explain the common indications and types of treatment, (3) describe new imaging modalities for RB, and (4) describe the role of a liquid biopsy in RB management. Questions received from registration and during the webinar will also be discussed. (Level: All)

Lecturer: Dr. Jesse Berry, Ophthalmologist, Children's Hospital Los Angeles, USA

Register here: https://live.cybersight.org/register/97745420743?lang=en

Dr. David Abramson and Guillermo Chantada will lead a discussion and four presentations on the state of knowledge of cfDNA in blood in retinoblastoma patients.

Zoom Link to Join

Please consider joining us for our summer case series! We will be discussing interesting conjunctival tumor cases. This will be an interactive discussion with experts in the field.

Speakers include: Carolina Gentile, MD; Carol Karp, MD; Carol Shields, MD; Jill Wells, MD
Moderator: Erica Alvarez Gonzalez, MD

Join us for the first Rb-NET MDT meeting focusing on the clinical – radiological – pathological correlation in retinoblastoma. We will have two case presentations and the presenters and panelists will include pediatric oncologist, ophthalmologists, radiologists and pathologists.

Link to Register for Event: http://us02web.zoom.us/j/86408785130

Meeting moderator: Petra Ketteler (Germany)
Imaging panel: Pim de Graaf (The Netherlands), Hervé Brisse (France) and Selma Sirin (Germany)
Pathology panel: Geeta Kashyap Vemuganti (India) and Anita Chan (Singapore)
Presentation 1st case (UK): Ashwin Reddy (clinical), Ulrike Loebel (imaging) and Victoria Bryant (pathology)
Presentation 2nd case (Israel): Didi Fabian (clinical), Shai Shrot (imaging) and Jonathan Weidenfeld (pathology)

Defining the roles of genetic drivers of uveal melanoma with cell-based and Drosophila models

Institut Curie, AmphitheaterHélène Martel-Massignac (BDD), 11 rue Pierre et Marie Curie, Paris The seminar will also be broadcasted online viaTeams*

Uveal melanoma is the most common eye cancer in adults with a set of highly characteristic genetic alterations. We identified mutations in the BAP1 (BRCA1 Associated Protein 1) gene in uveal melanomas with high likelihood of metastasis and recurrent mutations in the splicing factor SF3B1 with less chance of metastasis.

Theme: Retinoblastoma in Asia: Challenges and Solutions

You are cordially invited to the 2nd Asian Rb Group Symposium to be held during the World Retinoblastoma Awareness Week.

Organizers: Bhavna Chawla, India and Ido Didi Fabian, Israel

The meeting will be held online in the form of a panel discussion.

Topics for discussion - Retinoblastoma presentation, available modalities, new initiatives, management expenses, barriers to care, research needs, and role of the Asian Rb Group.

Expert Panel:

• Duangnate Rojanaporn, Thailand

• Tatiana L. Ushakova, Russia

• Shabana Choudhary, Pakistan

• Junyang Zhao, China

• Rita S. Sitorus, Indonesia

• Jason C. Yam, Hong Kong

  
  

  
  Registration is free

• Link to Register for Event: http://us02web.zoom.us/j/86771478407

  
  
  No pre-registration needed
  Use the time zone converter to find your local time.

WillsEye Hospital sponsors this monthly webinar, Shields Ocular Oncology Rounds the fourth Tuesday of every month.

Start time: at 6:45 a.m. EST

Three cases are reviewed and commented on by interested ophthalmologists worldwide. It is well received, with about 100 participants each month.

Join Via Zoom

DR Abramson and Chantada Rb webinar ( worldwide participation)

Reminder: Dr. Abramson would like to invite you to THIS​​ Friday's Retinoblastoma Online Case Study Meeting. It will take place THIS​ ​Friday, April 5th, 2024 at 2pm New York time.
Meeting link: https://sjdhospitalbarcelona.zoom.us/j/93107503728
Password: 166303